Skip to main content
永顺生物 logo

永顺生物 — Investor Relations & Filings

Ticker · 920729 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2025-09-14 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920729

About 永顺生物

https://www.winsun-gd.com/

Guangdong Winsun Bio-Pharmaceutical Co., Ltd. is a specialized enterprise focused on the research, development, production, and distribution of veterinary biological products. The company primarily develops vaccines for livestock and poultry, with a significant emphasis on swine and avian health. Its product portfolio includes live and inactivated vaccines targeting major diseases such as classical swine fever, porcine reproductive and respiratory syndrome (PRRS), and avian influenza. Winsun Bio-Pharmaceutical leverages advanced biotechnology to provide comprehensive animal disease prevention and control solutions. The company maintains a strong focus on technological innovation and quality management, operating multiple GMP-certified production lines to ensure the efficacy and safety of its biological preparations. Its research initiatives often involve collaborations with academic institutions to advance veterinary medicine and support the animal husbandry sector.

Recent filings

Filing Released Lang Actions
广东君信经纶君厚律师事务所关于广东永顺生物制药股份有限公司 2025 年第一次临时股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a legal opinion letter by a law firm regarding the company’s 2025 first extraordinary general meeting. It provides detailed voting results for each resolution, confirming validity of convening, attendance and outcome. This aligns with “Declaration of Voting Results & Voting Rights Announcements” since it officially reports shareholder vote outcomes at a general meeting.
2025-09-14 Chinese
第五届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 11th meeting of the 5th Board of Directors of Guangdong Yongshun Biopharmaceutical Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to various internal management system revisions and board member appointments. The content focuses on board decisions, governance structure changes, and internal policies rather than financial results or audit opinions. It also references announcements of related documents on the stock exchange platform but does not itself contain financial statements or audit reports. Therefore, this document fits best under the category of Board/Management Information (MANG), as it primarily concerns board meeting resolutions and management changes.
2025-08-25 Chinese
董事和高级管理人员离职管理制度
Board/Management Information Classification · 95% confidence The document is titled '董事和高级管理人员离职管理制度' which translates to 'Board and Senior Management Resignation Management System'. It details the internal management system regarding the resignation and departure procedures of the company's directors and senior management personnel. The content includes rules, obligations, and procedures related to board and senior management changes, but it is not an announcement of a specific personnel change, nor is it a report of financial results or governance structure. It is a detailed governance-related policy document. Therefore, it fits best under 'Board/Management Information (MANG)' which covers announcements and information about changes or policies related to the company's board or senior management. The document length is 3082 characters, which is sufficient for a detailed policy document rather than a brief announcement. There is no indication that this is a report publication announcement or a regulatory filing fallback. Hence, the classification is MANG with high confidence.
2025-08-25 Chinese
关于取消监事会并修订《公司章程》公告
Governance Information Classification · 95% confidence The document is a detailed announcement from Guangdong Yongshun Biological Pharmaceutical Co., Ltd. regarding the cancellation of the Supervisory Board and proposed amendments to the company's Articles of Association (公司章程). It includes extensive legal and regulatory references, detailed changes to corporate governance rules, shareholder rights, board responsibilities, and other internal company regulations. The content is focused on governance structure and company bylaws rather than financial results, audit opinions, or shareholder meeting results. It is not a financial report, earnings release, or voting results announcement. The document is a governance-related disclosure about changes to the company's internal rules and board structure. Therefore, it fits best under the category of Governance Information (CGR). The document length and detail confirm it is the actual governance document, not just an announcement of publication or a brief summary.
2025-08-25 Chinese
独立董事专门会议工作制度
Governance Information Classification · 95% confidence The document is titled '独立董事专门会议工作制度' which translates to 'Independent Directors Special Meeting Work System'. It details the internal governance rules and procedures for independent directors' meetings, including meeting convening, voting, and responsibilities. It references company law, securities law, stock exchange listing rules, and internal company bylaws. The document is a formal announcement of a governance policy or internal board procedure rather than a financial report, earnings release, or regulatory filing about financial results. It is not a report of management changes, nor a voting result announcement. It is a governance-related document describing internal rules and board structure. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 2534 characters, which is substantive for a governance policy document, not a brief announcement or certification.
2025-08-25 Chinese
内幕信息管理制度
Governance Information Classification · 95% confidence The document is titled as an "Insider Information Management System" issued by the board of Guangdong Yongshun Biopharmaceutical Co., Ltd. It details internal policies and procedures related to insider information management, confidentiality obligations, and regulatory compliance. The document includes board meeting resolutions and references to legal and regulatory frameworks but does not contain financial statements, earnings data, or audit results. It is a governance-related document focusing on internal control and compliance rather than financial reporting or announcements. Therefore, it fits best under Governance Information (CGR). The document length (6723 characters) and detailed policy content support this classification rather than a brief announcement or regulatory filing.
2025-08-25 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.